These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9662229)

  • 21. Evolving applications for contrast ultrasound.
    Lindner JR
    Am J Cardiol; 2002 Nov; 90(10A):72J-80J. PubMed ID: 12450594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bubble dynamics involved in ultrasonic imaging.
    Postema M; Schmitz G
    Expert Rev Mol Diagn; 2006 May; 6(3):493-502. PubMed ID: 16706749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular imaging with targeted contrast ultrasound.
    Kaufmann BA; Lindner JR
    Curr Opin Biotechnol; 2007 Feb; 18(1):11-6. PubMed ID: 17241779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of deeply located acute intravascular thrombi with therapeutic ultrasound guided by diagnostic ultrasound and intravenous microbubbles.
    Tsutsui JM; Xie F; Johanning J; Lof J; Cory B; He A; Thomas L; Matsunaga T; Unger E; Porter TR
    J Ultrasound Med; 2006 Sep; 25(9):1161-8. PubMed ID: 16929017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Targeted adhesion of platelet receptor-specific microbubble agent to thrombus in vitro].
    Ou WC; Xiu JC; Xie JG; Zha DG; Liu J; Hao R; Bin JP; Liu YL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):672-4. PubMed ID: 15958305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin-Activatable Microbubbles as Potential Ultrasound Contrast Agents for the Detection of Acute Thrombosis.
    Lux J; Vezeridis AM; Hoyt K; Adams SR; Armstrong AM; Sirsi SR; Mattrey RF
    ACS Appl Mater Interfaces; 2017 Nov; 9(43):37587-37596. PubMed ID: 28994575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding properties of flowing fibrin-targeted microbubbles evaluated with a thrombus-embedded microchannel.
    Li J; Zhang Y; Zou C; Chen Y; Li Y; Chen H
    Lab Chip; 2022 Jun; 22(12):2292-2298. PubMed ID: 35616180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo ultrasound visualization of non-occlusive blood clots with thrombin-sensitive contrast agents.
    Nakatsuka MA; Barback CV; Fitch KR; Farwell AR; Esener SC; Mattrey RF; Cha JN; Goodwin AP
    Biomaterials; 2013 Dec; 34(37):9559-65. PubMed ID: 24034499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics.
    Ammi AY; Lindner JR; Zhao Y; Porter T; Siegel R; Kaul S
    Thromb Haemost; 2015 Jun; 113(6):1357-69. PubMed ID: 25809056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insonation frequency selection may assist detection and therapeutic delivery of targeted ultrasound contrast agents.
    Payne E; Ooi A; Manasseh R
    Ther Deliv; 2011 Feb; 2(2):213-22. PubMed ID: 22833947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging with targeted contrast ultrasound.
    Piedra M; Allroggen A; Lindner JR
    Cerebrovasc Dis; 2009; 27 Suppl 2(Suppl 2):66-74. PubMed ID: 19372662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I clinical trials of MRX-115. A new ultrasound contrast agent.
    Fritz TA; Unger EC; Sutherland G; Sahn D
    Invest Radiol; 1997 Dec; 32(12):735-40. PubMed ID: 9406013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice.
    Wang X; Hagemeyer CE; Hohmann JD; Leitner E; Armstrong PC; Jia F; Olschewski M; Needles A; Peter K; Ahrens I
    Circulation; 2012 Jun; 125(25):3117-26. PubMed ID: 22647975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate.
    Xing Z; Ke H; Wang J; Zhao B; Yue X; Dai Z; Liu J
    Acta Biomater; 2010 Sep; 6(9):3542-9. PubMed ID: 20226284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbubbles and ultrasound: from diagnosis to therapy.
    Dijkmans PA; Juffermans LJ; Musters RJ; van Wamel A; ten Cate FJ; van Gilst W; Visser CA; de Jong N; Kamp O
    Eur J Echocardiogr; 2004 Aug; 5(4):245-56. PubMed ID: 15219539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study.
    Nishioka T; Luo H; Fishbein MC; Cercek B; Forrester JS; Kim CJ; Berglund H; Siegel RJ
    J Am Coll Cardiol; 1997 Aug; 30(2):561-8. PubMed ID: 9247533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound-induced gas release from contrast agent microbubbles.
    Postema M; Bouakaz A; Versluis M; de Jong N
    IEEE Trans Ultrason Ferroelectr Freq Control; 2005 Jun; 52(6):1035-41. PubMed ID: 16118985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of lactadherin-bearing clinically available microbubbles as ultrasound contrast agent for angiogenesis.
    Otani K; Yamahara K
    Mol Imaging Biol; 2013 Oct; 15(5):534-41. PubMed ID: 23539172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.